Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Designing economic evaluations to facilitate optimal decisions: the need to avoid bias

Authors Lee KM, Coyle K, Coyle D

Received 21 November 2015

Accepted for publication 26 November 2015

Published 5 April 2016 Volume 2016:8 Pages 73—76


Checked for plagiarism Yes

Editor who approved publication: Professor Giorgio Lorenzo Colombo

Karen M Lee,1,3 Kathryn Coyle,2 Doug Coyle2,3

1Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada; 2Health Economics Research Group, Brunel University, Uxbridge, UK; 3School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada

Guertin et al1 argue in their article “Bias within economic evaluations” that if researchers
fail to incorporate the future availability of generics entrants for new patented drugs, the incremental cost-effectiveness ratio (ICER) will be overestimated.1 Before addressing the validity of this argument, it is first worthwhile to consider the nature of both bias and economic evaluation.

Read the original paper by Guertin et al


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

Johnson BH, Bonafede MM, Watson C

ClinicoEconomics and Outcomes Research 2016, 8:53-61

Published Date: 23 February 2016

Ignoring the sacroiliac joint in chronic low back pain is costly

Polly DW, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:23-31

Published Date: 21 January 2016

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010